T1	Participants 108 145	T1-2 glottic squamous cell carcinomas
T2	Participants 329 352	early glottic carcinoma
T3	Participants 375 425	Patients with T1-2 glottic carcinoma were eligible
T4	Participants 444 556	Although 282 patients were required, the study was closed prematurely due to poor accrual with only 156 patients
T5	Participants 1402 1438	patients with T1-2 glottic carcinoma
